The ₹871.05 crore initial public offering (IPO) of dialysis services provider Nephrocare Health Services, which operates the NephroPlus brand, opens for subscription on December 10 and closes on December 12.

Ahead of the launch, the company raised ₹260 crore from anchor investors at ₹460 per share, according to an exchange filing.

Key anchor investors include SBI Healthcare Opportunities Fund, ICICI Prudential Mutual Fund, Fidelity Funds, DSP Healthcare Fund, The Prudential Assurance Company Limited, Eastspring Investments, Polar Capital Funds, Manulife Global Fund, Baroda BNP Paribas Small Cap Fund, Bandhan Small Cap Fund, SBI Life Insurance and HDFC Life Insurance.

SBI Securities has recommended subscribing at the cut-off price, citing the company's market leadership, expanding inte

See Full Page